Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Greece

European Research Council grant · Running

MetaReg Next-Gen Immunomodulatory Nanoplatforms Targeting Regulatory T Cell Metabolism to combat cancer

Coordinator
Idryma Iatroviologikon Ereunon Akademias Athinon, Greece
Runs
1 May 2027 to 31 October 2028
Status
Running
EU funding
€150k
Total cost
—
Partners
1 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101287771

What the project is doing

In the project's own words, from its summary on CORDIS.

Regulatory T cells (Tregs) are vital for maintaining homeostasis and self-tolerance. This immunosuppressive nature is exploited by cancer for tumour growth. Consequently, Treg accumulation in tumors is associated with poor prognosis and is a fundamental impediment to the success of immunotherapy. Thus, Treg suppressive mechanisms emerge as appealing therapeutic targets. However, current approaches focus on their systemic elimination, failing to yield significant clinical outcomes and are accompanied by harmful autoimmune toxicities.

The ERC-funded project RegSign discovered a novel, unexpected metabolic mechanism whose therapeutic targeting has the unique advantage of restraining the immunosuppressive action of Tregs specifically in the tumor, without eliminating them, while protecting their beneficial effect on the periphery. Based on these findings, this PoC project, MetaReg will develop and validate Treg-targeted nanoplatforms tailoring Treg metabolism to disrupt their immunosuppressive function specifically in tumors while preserving their fitness in the periphery.

To navigate the pathway from research to innovation, MetaReg will optimize the nanosystems, demonstrate their safety and efficacy in humanized mouse models, secure IP, and assess licensing strategies. MetaReg envisions bridging the “valley of death” between fundamental discoveries and clinical translation, opening new avenues in cancer immunotherapy.

Topics

Who is involved

OrganisationCityCountryRole
Idryma Iatroviologikon Ereunon Akademias AthinonAthinaGreeceCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI